AFM
ABBV icon

Anson Funds Management’s AbbVie ABBV Stock Holding History

Anson Funds Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,000
Closed -$1.47M – 88
2020
Q2 		$1.47M Hold
15,000
– – 0.38% 25
2020
Q1 		$1.14M Buy
+15,000
New +$1.28M 0.47% 35

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Anson Funds Management's ABBV Position: Q3 2020 in Review

Anson Funds Management sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 15,000 shares — an estimated $1.47M sold.

Anson Funds Management first reported a position in ABBV in Q1 2020 and held it in 2 quarters. The position peaked at $1.47M in Q2 2020. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Anson Funds Management reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • Anson Funds Management sold 15,000 AbbVie shares in Q3 2020, an estimated $1.47M.
  • Anson Funds Management first reported a position in AbbVie in Q1 2020 and held it in 2 quarters.
  • Anson Funds Management's AbbVie position peaked at $1.47M in Q2 2020.
  • 2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Anson Funds Management's 13F filing for Q3 2020, filed 16 Nov 2020.